Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease.

PURPOSE AND METHODS In this study, we examined the fiber-type proportions, cross-sectional areas (CSA), and capillarization from needle biopsies of the vastus lateralis muscle in 20 patients with chronic obstructive pulmonary disease (COPD) (FEV1 = 37 +/- 11% predicted, peak VO2 = 13 +/- 4 mL.min-1.kg-1) and nine age-matched normal subjects (peak VO2 = 33 +/- 7 mL.min-1.kg-1). The effects of endurance training on these parameters were also evaluated in 11 of the 20 patients with COPD. RESULTS The proportion of Type I fiber was smaller in COPD than normals (34 +/- 14% vs 58 +/- 16 in normals, P < 0.0005) with a corresponding increase in Type IIb fiber (P = 0.015). The CSA of Type I, IIa, and IIab fibers was also smaller in COPD. The capillary to fiber ratio tended to be reduced in patients, but this difference did not reach statistical significance (P = 0.15). The number of capillary contact for Type I, IIa, and IIab fibers was significantly reduced in COPD compared with normal subjects (P < 0.05). When corrected for the CSA, this parameter was similar for both groups. After training, peak VO2 increased by 11% (P < 0.05), the fiber-type proportion remained unchanged, and the CSA of Type I and IIa fibers increased by 31 and 21%, respectively (P < 0.05). Although the number of capillary contact for each fiber types increased with training, the capillary to fiber ratio and the number of capillary contact for the different fiber types relative to their CSA remain unchanged. CONCLUSIONS We conclude that in COPD, 1) the vastus lateralis muscle is characterized by a marked decrease in Type I fiber proportion, an increase in Type IIb fiber proportion, a decrease in Type I, IIa, and IIab fiber CSA and by a relatively preserved capillarization; and 2) a 12-wk training program induces a significant increase in Type I and IIa CSA.

[1]  L. Larsson,et al.  Lower limb skeletal muscle function after 6 wk of bed rest. , 1997, Journal of applied physiology.

[2]  F. Maltais,et al.  Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[3]  M. Decramer,et al.  Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[4]  M. Decramer,et al.  Peripheral muscle weakness contributes to exercise limitation in COPD. , 1996, American journal of respiratory and critical care medicine.

[5]  F. Maltais,et al.  Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. , 1996, American journal of respiratory and critical care medicine.

[6]  P. Wagner,et al.  Determinants of maximal oxygen transport and utilization. , 1996, Annual review of physiology.

[7]  N. Jones,et al.  Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. , 1995, American journal of respiratory and critical care medicine.

[8]  E. Wouters,et al.  Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. , 1995, American journal of respiratory and critical care medicine.

[9]  David N. Proctor,et al.  Oxidative capacity of human muscle fiber types: Effects of age and training status , 1995 .

[10]  N. Jones,et al.  Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. , 1992, Thorax.

[11]  F. Cobb,et al.  Altered Skeletal Muscle Metabolic Response to Exercise in Chronic Heart Failure: Relation to Skeletal Muscle Aerobic Enzyme Activity , 1991, Circulation.

[12]  P. Cerretelli,et al.  Muscle structure and performance capacity of Himalayan Sherpas. , 1991, Journal of applied physiology.

[13]  K. Hellström,et al.  Does chronic hypoxaemia induce transformations of fibre types? , 1991, Acta physiologica Scandinavica.

[14]  L. Jorfeldt,et al.  Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. , 1990, The European respiratory journal.

[15]  F. Cobb,et al.  Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. , 1990, Circulation.

[16]  C S Houston,et al.  Operation Everest II: adaptations in human skeletal muscle. , 1989, Journal of applied physiology.

[17]  L. Larsson,et al.  Effects of long‐term physical training and detraining on enzyme histochemical and functional skeletal muscle characteristics in man , 1985, Muscle & nerve.

[18]  E. Coyle,et al.  Effects of detraining on responses to submaximal exercise. , 1985, Journal of applied physiology.

[19]  E. Coyle,et al.  Time course of loss of adaptations after stopping prolonged intense endurance training. , 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.

[20]  J. Fridén,et al.  How to calculate human muscle fibre areas in biopsy samples--methodological considerations. , 1984, Acta physiologica Scandinavica.

[21]  E. Coyle,et al.  Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. , 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.

[22]  V. Sahgal,et al.  Fiber size and energy metabolites in five separate muscles from patients with chronic obstructive lung diseases. , 1983, Respiration; international review of thoracic diseases.

[23]  P D Gollnick,et al.  Effects of disuse on the structure and function of skeletal muscle. , 1983, Medicine and science in sports and exercise.

[24]  B. Saltin,et al.  Morphology and enzymatic capacity in arm and leg muscles in 78-81 year old men and women. , 1982, Acta physiologica Scandinavica.

[25]  K Klausen,et al.  Adaptive changes in work capacity, skeletal muscle capillarization and enzyme levels during training and detraining. , 1981, Acta physiologica Scandinavica.

[26]  K. Mabuchi,et al.  Actomyosin ATPase. I. Quantitative measurement of activity in cryostat sections , 1980, Muscle & nerve.

[27]  R T Withers,et al.  Muscle respiratory capacity and fiber type as determinants of the lactate threshold. , 1980, Journal of applied physiology: respiratory, environmental and exercise physiology.

[28]  J. Henriksson,et al.  Capillary supply of the quadriceps femoris muscle of man: adaptive response to exercise , 1977, The Journal of physiology.

[29]  A. Sargeant,et al.  Functional and structural changes after disuse of human muscle. , 1977, Clinical science and molecular medicine.

[30]  P. Andersen,et al.  Capillary density in skeletal muscle of man. , 1975, Acta physiologica Scandinavica.

[31]  P. Vignos,et al.  Experimental corticosteroid myopathy. , 1969, Arthritis and rheumatism.

[32]  L. Eriksen,et al.  The ether soluble porphyrins found in the urine of normal man and rabbit. , 1962, Scandinavian journal of clinical and laboratory investigation.